ArticleAmerican journal of ophthalmology case reports2025
Third nerve palsy as first presenting symptom of Guillain-Barre Syndrome spectrum clinical variant.
Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hospital Coordination and Protocols Using Serum and Peripheral Blood Cells from Patients and Healthy Donors in a Longitudinal Study of Guillain-Barré Syndrome.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To report an unusual presentation of a Guillain-Barre Syndrome (GBS) spectrum clinical variant with an initial isolated, unilateral third nerve palsy prior to development of areflexia and lower extremity weakness. Observations: A 16-month-old presented with a pupil-involving right third nerve palsy and normal lower extremity strength and reflexes. She was treated with a short oral steroid taper for presumed post-infectious cranial nerve (CN) palsy and had initial improvement. Soon after completing the taper, she developed an inability to sit, stand, or crawl with lower extremity areflexia. Magnetic resonance imaging of the spine showed diffusely thickened and enhancing cauda equina nerve roots and lumbar puncture showed isolated elevated protein, consistent with a diagnosis of a GBS spectrum disorder. She was treated with intravenous immunoglobulin and had complete resolution of ptosis as well as normal extraocular movements. Conclusions and importance: Pediatric cases of acute third nerve palsy are most often traumatic, neoplastic, vascular, or demyelinating. These cases are less likely to have a post-viral etiology in contrast to the more commonly encountered acquired sixth nerve palsy. An isolated, unilateral third nerve palsy is a rare presentation of GBS and its clinical variant Miller Fisher Syndrome. This case demonstrates the importance of a high level of suspicion, particularly in the context of worsening systemic symptoms, to include these demyelinating disorders as a possible cause of unilateral CN palsy, as they can have a good prognosis if treated appropriately.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.